WASHINGTON, July 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Almon Healthcare Private Limited from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Rajesh Gandhi, Chairman, Almon Healthcare Private Limited, Plot No 4, Sankalp Industrial Estate, Behind Kerala GIDC, Bavala, Ahmedabad 382240 Gujarat, India

Issuing Office: Center for Drug Evaluation and Research (CDE . . .

Click here for more information about our products